Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC3937 Ouabain
Natural inhibitor of the Na+/K+-ATPase sodium-potassium ion pump
More description
DCC3936 Ota-5781
Novel potent inhibitor of the natural function of FDX1, promoting a unique form of copper-dependent cell death
More description
DCC3935 Osu-53
Novel AMPK activator, inhibiting mTOR signaling and autophagy stimulation, activating mutations in RAS or BRAF
More description
DCC3934 Osteosarcoma-in-d15
Novel Inhibitor of Migration and Invasion of Osteosarcoma Cells Mediated by p53, Regulating EMT-Related Genes
More description
DCC3933 Osteosarcoma-in-d14
Novel Inhibitor of Migration and Invasion of Osteosarcoma Cells Mediated by p53, Regulating EMT-Related Genes
More description
DCC3932 Osteoprotegerin
Soluble secreted member of the tumor necrosis factor receptor superfamily, inhibiting osteoclastogenesis by interrupting the signaling between stromal cells and osteoclastic progenitor cells, leading to excess accumulation of bone and cartilage
More description
DCC3931 Osteoclast Differentiation Inhibitor T63
Novel inhibitor of osteoclast differentiation through regulating MAPKs and Akt signaling pathways
More description
DCC3930 Osl-95ii
Inhibitor of the glycan-processing enzyme endoplasmic-reticular glucosidase
More description
DCC3929 Osi-461
Novel cGMP phosphodiesterase (cGMP-PDE) inhibitor
More description
DCC3928 Osi-296
Novel potent, orally efficacious, dual inhibitor of cMET and RON kinases
More description
DCC3927 Oseltamivir Hydrochloride
Inhibitor of the influenza neuramidase enzyme, blocking neuraminidases on the surfaces of influenza viruses, interfering with host cell release of complete viral particles
More description
DCC3926 Ortataxel
Second-generation taxane derivative with potential antineoplastic activity, binding to and stabilizing tubulin molecules, inhibiting cell division and cellular proliferation
More description
DCC3925 Orp-101
Peripheral weak partial mu-opioid receptor agonist and a weak kappa-opioid receptor antagonist, preventing from being absorbed and entering the central nervous system
More description
DCC3924 Oroidin Hydrochloride
Inhibitor of an enzyme responsible for the multidrug resistance phenotype in the yeast Saccharomyces cerevisiae.
More description
DCC3923 Orn0829
Novel potent dual orexin 1/2 receptor (OX1/2R) antagonist for the treatment of insomnia
More description
DCC3922 orm-10103
Novel sodium/calcium exchanger (NCX) inhibitor
More description
DCC3921 Oritavancin
Lipoglycopeptide Antibacterial, acting as a inhibitor of Cytochrome P450 2C19/2C9, and a inducer of Cytochrome P450 3A4/2D6
More description
DCC3920 Org48762-0
Selective p38alpha and p38beta kinase inhibitor
More description
DCC3919 Org-29647
CB1 allosteric modulator
More description
DCC3918 Org-27759
Negative allosteric modulator at the CB1 receptor
More description
DCC3917 Orex-1019
Novel mixed κ/μ receptor antagonist. having therapeutic potential for the treatment of depression and other stress-induced conditions
More description
DCC3916 Orcein
Collagen immunostain
More description
DCC3915 Orc-13661 Hydrochloride
Novel Potent, Well Tolerated, and Orally Active Protective Agent against Aminoglycoside-Induced Hearing Loss
More description
DCC3914 Optoglunam4.1
Novel negative allosteric modulator (NAM) of mGlu4, being isomerized with blue-light/dark cycles with fast relaxation
More description
DCC3913 Ophiobolin A
Inhibitor of calmodulin action in calcium regulation
More description
DCC3912 Opc-14117
Antioxidant and free radical scavenger, attenuating edema formation, and subsequent tissue damage following cortical contusion
More description
DCC3911 Opc-13213
Metabolite of Cilostazol
More description
DCC3910 Oopz-23-l(nle)aq
Novel potent inhibitor of protein-protein interactions
More description
DCC3909 Ono-ae3-237
Potent, selective, and orally active prostaglandin D2 receptor antagonist
More description
DCC3908 Ono-ae-248
Novel selective EP3 receptor agonist
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X